Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001853327-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 4, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
22,500
Total Value
$478,826.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 7,500 | $14.50 | $108,750.00 | 105,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 1, 2026 | Sale | 6,200 | $49.21 | $305,102.00 | 99,294 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 1, 2026 | Sale | 1,300 | $49.98 | $64,974.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 394,857 | Direct | โ | View Details |